Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
May 27, 2008
Patent Application Number
11193746
Date Filed
July 29, 2005
Patent Citations Received
Patent Primary Examiner
Patent abstract
Methods of treating diabetes in mammals, particularly humans, by blocking or inhibiting VEGF-mediated activity. A preferred inhibitor of VEGF-mediated activity is a VEGF antagonist such as the VEGF fusion protein trap of SEQ ID NO:2 capable of binding and blocking VEGF. The method of the invention may be combined with other therapies, such as with insulin therapy.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.